Relmada TherapeuticsRLMD
13F holders, Q2 2025 (June 30)50holders +6
13new positions
7sold out
1famous investor
$0.60avg. 13F price*
At the end of Q2 2025, 50 institutions reported holding Relmada Therapeutics Inc. (RLMD) in their 13F filings, up 6 from Q1 2025. 13 opened new positions and 7 sold out. The largest holders were Driehaus Capital Management LLC ($444K), Acadian Asset Management LLC ($371K) and BlackRock, Inc. ($305K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Relmada Therapeutics Inc.
- CUSIP
- 75955J402
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $917K |
| Exits | 7 | $196K |
All 13F filers, Q1 2025 → Q2 2025: 1,721,752 shares bought and 2,638,091 shares sold, net −916,339 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 50 holders
| Driehaus Capital Management LLC | 0.00% | New | 740,006 | $444K |
| Acadian Asset Management LLC | 0.00% | Reduce -49.5% | 619,479 | $371K |
| BlackRock, Inc. | 0.00% | Reduce -10.4% | 508,000 | $305K |
| AdvisorShares Investments LLC | 0.04% | Add +43.4% | 396,514 | $238K |
| Vanguard Group Inc. | 0.00% | Reduce -69.9% | 364,077 | $218K |
| Geode Capital Management, LLC | 0.00% | Add +0.2% | 302,354 | $182K |
| Deutsche Bank AG | 0.00% | No change | 224,846 | $135K |
| Corient Private Wealth LP | 0.00% | New | 206,667 | $120K |
| UBS Group AG | 0.00% | Add +24.6% | 180,471 | $108K |
| Parsons Capital Management Inc. | 0.01% | No change | 163,336 | $98K |
| RBF Capital, LLC | 0.00% | No change | 163,261 | $98K |
| Marshall Wace, LLP | 0.00% | New | 154,568 | $93K |
| Renaissance Technologies | 0.00% | Add +20.9% | 150,100 | $90K |
| ADAR1 Capital Management, LLC | 0.01% | New | 130,000 | $78K |
| Jane Street Group, LLC | 0.00% | New | 114,354 | $69K |
| State Street Corp. | 0.00% | No change | 106,735 | $64K |
| Mgo One Seven LLC | 0.00% | No change | 100,000 | $60K |
| Two Sigma Investments, LP | 0.00% | Reduce -44.0% | 95,417 | $57K |
| Susquehanna International Group, LLP | 0.00% | New | 65,803 | $40K |
| Northern Trust Corp. | 0.00% | No change | 59,571 | $36K |
| LMR Partners LLP | 0.00% | New | 55,104 | $33K |
| apricus wealth, LLC | 0.02% | Reduce -3.1% | 47,462 | $28K |
| XTX Topco Ltd | 0.00% | New | 46,039 | $28K |
| Ikarian Capital, LLC | 0.01% | No change | 40,270 | $24K |
| AlTi Global, Inc. | 0.00% | No change | 31,975 | $19K |
| Wealthedge Investment Advisors, LLC | 0.01% | No change | 28,000 | $17K |
| Group One Trading LLC | 0.00% | Reduce -8.2% | 26,301 | $16K |
| Two Sigma Advisers, LP | 0.00% | Reduce -91.3% | 25,100 | $15K |
| Robertson Stephens Wealth Management, LLC | 0.00% | No change | 25,000 | $15K |
| Tortoise Investment Management, LLC | 0.00% | No change | 21,676 | $13K |
| World Investment Advisors | 0.00% | No change | 21,644 | $13K |
| Pandora Wealth, Inc. | 0.01% | No change | 20,000 | $12K |
| Ground Swell Capital, LLC | 0.02% | New | 15,320 | $9K |
| Lido Advisors, LLC | 0.00% | No change | 13,905 | $8K |
| HRT Financial LP | 0.00% | Reduce -76.6% | 12,162 | $7K |
| Bedel Financial Consulting, Inc. | 0.00% | No change | 10,000 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 6,189 | $4K |
| JPMorgan Chase & Co. | 0.00% | Add +3129.8% | 5,103 | $3K |
| American Capital Advisory, LLC | 0.00% | Reduce -50.0% | 1,954 | $1K |
| Simplex Trading, LLC | 0.00% | Reduce -45.9% | 2,427 | $1K |
| Morgan Stanley | 0.00% | Reduce -60.7% | 852 | $512 |
| Raymond James Financial Inc. | 0.00% | New | 587 | $352 |
| Bank of America Corp. | 0.00% | Reduce -97.6% | 324 | $194 |
| SBI Securities Co., Ltd. | 0.00% | No change | 102 | $61 |
| BNP Paribas Financial Markets | 0.00% | Add +20.8% | 87 | $52 |
| Osaic Holdings, Inc. | 0.00% | No change | 5 | $3 |
| Front Row Advisors LLC | 0.00% | Reduce -50.0% | 3 | $2 |
| Barclays PLC | 0.00% | New | 1 | $1 |
| Citigroup Inc. | 0.00% | No change | 2 | $1 |
| Royal Bank of Canada | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is RLMD's weight in each manager's 13F, not the share of Relmada Therapeutics Inc. the manager owns.